Nachrichten zur Novo-Nordisk AS Aktie

Novo Nordisk (NVO) Stock Moves -1.67%: What You Should Know

Novo Nordisk (NVO) closed at $67.10 in the latest trading session, marking a -1.67% move from the prior day.…

DTC obesity med market heats up: Eli Lilly taps knownwell, Hims & Hers adds new weight loss meds to platform

Hims & Hers is expanding access to Eli Lillys branded weight loss drug Zepbound and diabetes drug Mounjaro as well…

Bernstein belässt Novo Nordisk auf Market-Perform

NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Novo Nordisk auf "Market-Perform" mit einem Kursziel…

Goldman belässt Novo Nordisk auf Buy - Ziel 822 Kronen

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat Novo Nordisk mit einem Kursziel von 822 dänischen Kronen auf…

The Smartest Biotech Stocks to Buy With $50

One of the great things about equity markets is that you dont need a fortune to get started. Though strong…

Novo Nordisk: Aktie dreht ins Plus – Korrektur beendet?

Die Aktie von Novo Nordisk ist heute erneut mit einem deutlichen Minus und damit einem weiteren neuen 52-Wochen-Tief in den…

Novo Nordisk: Not As Bullish As Many

…

Denmark Stocks Slide Into Bear Market as Tariffs, Novo Weigh

Denmark’s benchmark stock index has fallen 21% from its September high, making it the first major European index to enter…

Novo Nordisk, BioNxt Solutions, Bayer Aktie: Drei Wege zu Gesundheit und Rendite

Die Pharmabranche boomt - und drei Unternehmen stehen 2025 besonders im Rampenlicht: Novo Nordisk, BioNxt Solutions und Bayer. Alle drei…

Why Hims & Hers Health Stock Couldnt Beat the Market Today

Hims & Hers Health (NYSE: HIMS) stock labored mightily on Wednesday, but in the end, it couldnt top the benchmark…

Novo Nordisk Aktie: US-Zölle und Produktionsprobleme belasten weiter

Kulmbach (www.aktiencheck.de) - Novo Nordisk-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

Novo Owner Targets More China Biotech Deals

Novo Holdings CEO Kasim Kutay says China has "really moved up the value chain" in healthcare. "Weve seen many others…

Coffers swelling on Wegovy sales, Novo Holdings doubles income and returns in 2024

Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk , nearly doubled annual income and investment returns to a…

LXRX Stock Moves Up 30% in a Week: What is Driving This Rally?

The upside comes after Lexicon lands a deal worth $1 billion for its experimental obesity drug with Novo Nordisk.…

Hims & Hers adds Eli Lilly GLP-1 drugs, Johnson & Johnson setback

Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to discuss some of the top stories of the trading day,…

Why Hims & Hers Health Stock Soared Tuesday

Shares of Hims & Hers Health (NYSE: HIMS) surged on Tuesday, closing the session up 5.25% after having been up…

Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 12.5% in the afternoon session after the company revealed it…

Hims & Hers to sell Lillys weight-loss drug on its telehealth platform (April 1)

Telehealth firm Hims & Hers Health NYSE:HIMS said on Tuesday it plans to sell Eli Lillys NYSE:LLY weight-loss drug, as…

Hims & Hers to sell Lillys weight-loss drug on its telehealth platform

Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lillys weight-loss drug, as it widens…

Europas Megastar-Aktie zum halben Preis – so stehen die Chancen auf das Comeback

Noch vor Kurzem war Novo Nordisk Europas wertvollster Konzern. Ein Börsenwert von einer Billion Euro schien realistisch. Dann jedoch folgte…

Novo Nordisk Buy

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Novo Nordisk auf "Buy" mit einem Kursziel von…

UBS belässt Novo Nordisk auf Buy - Ziel 750 Kronen

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Novo Nordisk auf "Buy" mit einem Kursziel von…

Opening Bell: Massive Aberkäufe durch Zoll-Angst; SMA, Aston Martin, Palantir, Novo Nordisk, Intel, Moderna & Co

US-Aktien-Futures geraten im vorbörslichen Handel wiederholt unter Druck, da Anleger auf Trumps sogenannten „Liberation Day“ am Mittwoch blicken. Dann treten…

Novo Nordisk’s Worst Month Since 2002 Shows Growth Concerns

As Novo Nordisk A/S shares head for their worst month in more than two decades, the days when the Danish…

Novo Nordisk Aktie: Kursziel um 100 DKK angepasst

New York (www.aktiencheck.de) - Rating-Update: Thibault Boutherin von Morgan Stanley stuft die Aktie von Novo Nordisk A/S (ISIN: DK0062498333, WKN: A3EU6F,…

Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors

…

1 Growth Stock With Major Catalysts on the Way to Buy and Hold

After starting 2024 strong, Eli Lilly (NYSE: LLY) did not perform well in the second half of last year. Its…

Novo Nordisks diabetes pill slashes risk of cardiovascular complications by 14% after four years

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established…

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating…

Ozempic® (once-weekly semaglutide 1.0 mg) shown to improve walking distance and quality of life in adults with type 2 diabetes and peripheral artery disease (PAD) at ACC 2025

Bagsværd, Denmark, 29 March 2025 – Novo Nordisk today presented the full results from STRIDE, a phase 3b peripheral artery…

dpa-AFX ProFeed